JBC INTERFERin siRNA transfection reagent

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M404416200 on September 2, 2004

J. Biol. Chem., Vol. 279, Issue 47, 48904-48914, November 19, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
279/47/48904    most recent
M404416200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weiser, D. C.
Right arrow Articles by Shenolikar, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weiser, D. C.
Right arrow Articles by Shenolikar, S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

The Inhibitor-1 C Terminus Facilitates Hormonal Regulation of Cellular Protein Phosphatase-1

FUNCTIONAL IMPLICATIONS FOR INHIBITOR-1 ISOFORMS*

Douglas C. Weiser{ddagger}, Suzanne Sikes, Shi Li, and Shirish Shenolikar§

From the Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, North Carolina 27710

Inhibitor-1 (I-1) is a selective inhibitor of protein phosphatase-1 (PP1) and regulates several PP1-dependent signaling pathways, including cardiac contractility and regulation of learning and memory. The human I-1 gene has been spliced to generate two alternative mRNAs, termed I-1{alpha} and I-1{beta}, encoding polypeptides that differ from I-1 in their C-terminal sequences. Reverse transcription-PCR established that I-1{alpha} and I-1{beta} mRNAs are expressed in a developmental and tissue-specific manner. Functional analysis of I-1 in a Saccharomyces cerevisiae strain dependent on human I-1 for viability established that a novel domain encompassing amino acids 77–110 is necessary for PP1 inhibition in yeast. Expression of human I-1 in S. cerevisiae with a partial loss-of-function eukaryotic initiation factor-2{alpha} (eIF2{alpha}) kinase (Gcn2p) mutation permitted growth during amino acid starvation, consistent with the inhibition of Glc7p/PP1, the yeast eIF2{alpha} phosphatase. In contrast, human I-1{alpha}, which lacks amino acids 83–134, and I-1 with C-terminal deletions were significantly less effective in promoting yeast growth under starvation conditions. These data suggest that C-terminal sequences of I-1 enhance regulation of the eukaryotic eIF2{alpha} phosphatase. In vitro studies established that C-terminal sequences, deleted in both I-1{alpha} and I-1{beta}, enhance PP1 binding and inhibition. Expression of full-length and C-terminally truncated I-1 in HEK293T cells established the importance of the I-1 C terminus in transducing cAMP signals that promote eIF2{alpha} phosphorylation. This study demonstrates that multiple domains in I-1 target cellular PP1 complexes and establishes I-1 as a cellular regulator of eIF2{alpha} phosphorylation.


Received for publication, April 21, 2004 , and in revised form, August 31, 2004.

* This work was supported in part by National Institutes of Health Grant RO1-DK52054 (to S. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

{ddagger} Supported by Predoctoral Fellowship DAMD17-02-1-0378 from the United States Department of Defense Breast Cancer Program.

§ To whom correspondence should be addressed: Dept. of Pharmacology and Cancer Biology, Duke University Medical Center, LSRC C315, Research Dr., Durham, NC 27710. Tel.: 919-681-6178/9; Fax: 919-681-9567; E-mail: sheno001{at}mc.duke.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
FASEB J.Home page
G. Chen, X. Zhou, P. Nicolaou, P. Rodriguez, G. Song, B. Mitton, A. Pathak, A. Zachariah, G.-C. Fan, G. W. Dorn II, et al.
A human polymorphism of protein phosphatase-1 inhibitor-1 is associated with attenuated contractile response of cardiomyocytes to {beta}-adrenergic stimulation
FASEB J, June 1, 2008; 22(6): 1790 - 1796.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. A. Gibbons, L. Kozubowski, K. Tatchell, and S. Shenolikar
Expression of Human Protein Phosphatase-1 in Saccharomyces cerevisiae Highlights the Role of Phosphatase Isoforms in Regulating Eukaryotic Functions
J. Biol. Chem., July 27, 2007; 282(30): 21838 - 21847.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Nguyen, A. Nishi, J. W. Kansy, J. Fernandez, K. Hayashi, F. Gillardon, H. C. Hemmings Jr., A. C. Nairn, and J. A. Bibb
Regulation of Protein Phosphatase Inhibitor-1 by Cyclin-dependent Kinase 5
J. Biol. Chem., June 1, 2007; 282(22): 16511 - 16520.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. A. Gibbons, D. C. Weiser, and S. Shenolikar
Importance of a Surface Hydrophobic Pocket on Protein Phosphatase-1 Catalytic Subunit in Recognizing Cellular Regulators
J. Biol. Chem., April 22, 2005; 280(16): 15903 - 15911.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.